NVIDIA and GE HealthCare have formed a groundbreaking collaboration to build autonomous
diagnostic imaging solutions beginning with X-ray and ultrasound. The collaboration was unveiled at
NVIDIA's GTC 2025 conference in San Jose, California, and may revolutionize medical imaging by
bringing intelligent automation and artificial intelligence (AI) into the radiology process.

GE HealthCare will employ NVIDIA's next-generation computing platforms to create AI-powered X-
ray and ultrasound systems, part of a broader industry trend where AI is becoming the standard in
medical diagnosis. The collaboration will employ NVIDIA's Isaac Healthcare and Jetson platforms,
which will be central to automating various tasks including patient positioning, image scanning, and
quality control. Isaac, who has been employed in AI-powered robotics in the past, and Jetson, the
industry leader, will be central to the automation process.

The companies anticipate that this AI technology will make X-ray and ultrasound imaging—two of
medicine's most widely utilized diagnostic technologies—more widespread. With the world's
diagnostic imaging market valued at $37.2 billion in 2024 and anticipated to reach nearly $55 billion
by 2033, AI technologies such as these are likely to drive the sector.

While the application of AI in diagnostic imaging is not new, developing fully autonomous systems
has proven difficult. NVIDIA claims that its intelligent automation software can construct digital
replicas of medical environments to test AI-based imaging solutions in real time. Isaac for Healthcare
supports multi-scale simulations, ranging from microscopic biological structures to full-scale hospital
environments, to enable the construction and deployment of AI models.

GE HealthCare intends to use this advanced technology to automate routine technologist tasks in X-
ray exam rooms. For ultrasound imaging, intelligent automation can streamline processes as well as
reduce the physical strain on medical professionals through repetitive motion.

This partnership is a continuation of earlier partnerships, such as the creation of SonoSAMTrack, a
research tool to segment anatomies, lesions, and other structures of interest from images obtained
by ultrasound. NVIDIA has also been growing its footprint in the life sciences market, with
partnerships in genomics, clinical trials, and AI-based healthcare solutions. The company Inception
program, hosting more than 3,500 healthcare startups, continues to encourage innovation in the
industry.

Even with these developments, however, NVIDIA has experienced stock market problems, in part
brought on by rising Chinese competition and concerns of an AI market bubble. During the GTC
conference, CEO Jensen Huang unveiled the company's most powerful AI processors to date, though
the announcement did not impact NVIDIA's stock activity in the short term.

With intelligent automation of medical imaging on the rise, the partnership between NVIDIA and GE
HealthCare is the next big step toward a world where autonomous diagnostic devices drive
efficiency, accuracy, and accessibility in healthcare.